BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 14605097)

  • 1. Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1.
    Wang DY; Fulthorpe R; Liss SN; Edwards EA
    Mol Endocrinol; 2004 Feb; 18(2):402-11. PubMed ID: 14605097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
    Sengupta K; Banerjee S; Saxena N; Banerjee SK
    Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen regulation in human breast cancer cells of new downstream gene targets involved in estrogen metabolism, cell proliferation and cell transformation.
    Vendrell JA; Magnino F; Danis E; Duchesne MJ; Pinloche S; Pons M; Birnbaum D; Nguyen C; Theillet C; Cohen PA
    J Mol Endocrinol; 2004 Apr; 32(2):397-414. PubMed ID: 15072547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells.
    Borrás M; Laios I; el Khissiin A; Seo HS; Lempereur F; Legros N; Leclercq G
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):203-13. PubMed ID: 8645630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
    Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
    Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domains of estrogen receptor alpha (ERalpha) required for ERalpha/Sp1-mediated activation of GC-rich promoters by estrogens and antiestrogens in breast cancer cells.
    Kim K; Thu N; Saville B; Safe S
    Mol Endocrinol; 2003 May; 17(5):804-17. PubMed ID: 12576490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
    Bianco NR; Perry G; Smith MA; Templeton DJ; Montano MM
    Mol Endocrinol; 2003 Jul; 17(7):1344-55. PubMed ID: 12714703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
    Ghosh MG; Thompson DA; Weigel RJ
    Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V; Gougelet A; Maillard S; Renoir JM
    Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel estrogen-responsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant.
    Liu HL; Golder-Novoselsky E; Seto MH; Webster L; McClary J; Zajchowski DA
    Mol Endocrinol; 1998 Nov; 12(11):1733-48. PubMed ID: 9817599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds.
    Boehme K; Simon S; Mueller SO
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):85-96. PubMed ID: 19371625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen and phorbol esters regulate amphiregulin expression by two separate mechanisms in human breast cancer cell lines.
    Martínez-Lacaci I; Saceda M; Plowman GD; Johnson GR; Normanno N; Salomon DS; Dickson RB
    Endocrinology; 1995 Sep; 136(9):3983-92. PubMed ID: 7649107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells.
    Scafoglio C; Ambrosino C; Cicatiello L; Altucci L; Ardovino M; Bontempo P; Medici N; Molinari AM; Nebbioso A; Facchiano A; Calogero RA; Elkon R; Menini N; Ponzone R; Biglia N; Sismondi P; De Bortoli M; Weisz A
    J Cell Biochem; 2006 Aug; 98(5):1163-84. PubMed ID: 16514628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of estrogens and antiestrogens on the expression of selected hormone-responsive genes.
    Sismondi P; Biglia N; Ponzone R; Fuso L; Scafoglio C; Cicatiello L; Ravo M; Weisz A; Cimino D; Altobelli G; Friard O; De Bortoli M
    Maturitas; 2007 May; 57(1):50-5. PubMed ID: 17395409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.